News

1 Surging Stock to Keep an Eye On and 2 to Turn Down
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to new ...
GE Vernova: Looks Like The Party Is Over
GE Vernova is well-positioned in power, wind, and electrification, with strong growth prospects. Find out why GEV stock is a ...
Patient Capital Management Q2 2025 Commentary
For the second quarter, the S&P 500 gained 10.9%, the Nasdaq 18.0% and the Dow 5.5%. Opportunity Equity Strategy rose 15.3% ...
StockStory.org on MSN6h
1 Healthcare Stock for Long-Term Investors and 2 to Be Wary Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID ...
Livewire Markets on MSN8h
The top 10 Aussie equity funds delivered north of 20% last FY (the best nearly doubled it)
In this wire, we crunch the data on the country's top-performing Aussie equities funds for FY25 and examine their positioning ...
The Manila Times19m
Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy
Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its treasury PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics, Inc., (NASDAQ: ...
Is Capital One a Buy Now That It Has Bought Discover?
From a big-picture perspective, Capital One is a bank and does a lot of normal bank things, like offering bank accounts and ...